Aims: The aim of this study was to evaluate the effects of the Buzzy device application on pain levels and comfort in newborns during heel stick procedures.
Methods: This randomized controlled experimental study was conducted at a Family Health Centre affiliated with the Public Health Directorate in a province in eastern Turkey between September and November 2024. The sample included 80 newborns born at 37–42 weeks of gestational age within the first 28 days of life (Buzzy group: n=40; control group: n=40). In the Buzzy group, the Buzzy device was applied approximately 30 seconds before the heel stick procedure. In the control group, the procedure was performed without any intervention. Data collection tools included the neonatal introduction form, the neonatal infant pain scale (NIPS), and the neonatal comfort behavior scale (NCBS). Ethical principles were adhered to throughout the study.
Results: Pain levels and comfort scores during the heel stick procedure were significantly better in the Buzzy group compared to the control group (p<0.001). Analysis revealed that, in the control group, pain levels increased significantly, and comfort levels decreased markedly during the procedure. In contrast, the Buzzy group exhibited a more limited increase in pain levels and a less pronounced decrease in comfort. After the procedure, the pain scores were significantly lower, and comfort levels were higher in the Buzzy group compared to the control group (p<0.001).
Conclusion: The Buzzy device was found to be an effective method for significantly reducing pain and maintaining comfort in newborns during heel stick procedures. These findings suggest that the Buzzy device can be a valuable tool for pain management and enhancing comfort in clinical settings. Future studies could explore the effectiveness of the device in larger populations and compare it with other pain management strategies.
This study was conducted following the ethical principles outlined in the Declaration of Helsinki. Written ethical approval was obtained from the Van Yüzüncü Yıl University Non-Interventional Clinical Research Ethics Committee (Decision No. 2023/06-02, dated June 16, 2023). Informed written and verbal consent was obtained from the parents of all participating infants prior to the study. Participation was entirely voluntary, and parents were informed of their right to withdraw from the study at any time without prejudice. The randomized controlled trial was registered on ClinicalTrials.gov (ID: NCT06773325). Ethical principles, including ensuring the safety, comfort, and well-being of the participants, were strictly adhered to throughout the study.
Primary Language | English |
---|---|
Subjects | Pediatric Health and Illnesses Nursing |
Journal Section | Research Articles |
Authors | |
Publication Date | March 21, 2025 |
Submission Date | January 23, 2025 |
Acceptance Date | February 23, 2025 |
Published in Issue | Year 2025 Volume: 7 Issue: 2 |
TR DİZİN ULAKBİM and International Indexes (1b)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show
Journal Indexes and Platforms:
TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.The indexes of the journal's are;
The platforms of the journal's are;
The indexes/platforms of the journal are;
TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit
EBSCO, DOAJ, OAJI is under evaluation.
Journal articles are evaluated as "Double-Blind Peer Review"